DeepMed Research

UNICANCER

🇧🇷Brazil

Country: 🇧🇷Brazil

Ownership: Private

Established: 1964-01-01

Employees: 101

Market Cap: -

Website: http://www.unicancer.fr

Clinical Trials

Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008

Recruiting

Conditions: Metastatic Breast Cancer

First Posted Date: 2017-09-07

Last Posted Date: 2025-04-25

Lead Sponsor: UNICANCER

Target Recruit Count: 40000

Registration Number: NCT03275311

Locations: 🇫🇷
Institut Bergonié, Bordeaux, France
🇫🇷
Institut de Cancérologie de l'Ouest - Paul Papin, Angers, France
🇫🇷
Centre François Baclesse, Caen, France

and more 17 locations

Evolution of the Therapeutic Care in Ovarian Cancer From 2011

Suspended

Conditions: Ovarian Cancer

First Posted Date: 2017-09-07

Last Posted Date: 2025-04-23

Lead Sponsor: UNICANCER

Target Recruit Count: 13331

Registration Number: NCT03275298

Locations: 🇫🇷
Centre Paul Strauss, Strasbourg, France
🇫🇷
Centre Léon Bérard, Lyon, France
🇫🇷
Centre Georges-François Leclerc, Dijon, France

and more 17 locations

Investigation of Tumour Spectrum of Germline Mutations in Breast and Ovarian Cancer Genes.

Not Applicable

Active, not recruiting

Conditions: Mutation
Hereditary Breast and Ovarian Cancer

Interventions: Other: Genetic testing

First Posted Date: 2017-08-11

Last Posted Date: 2024-12-12

Lead Sponsor: UNICANCER

Target Recruit Count: 7274

Registration Number: NCT03246841

Locations: 🇫🇷
Gustave Roussy, Paris, France
🇫🇷
Institut Curie - PIGE, Paris, France

Nivolumab in Recurrent and/or Metastatic SCCHN

Phase 2

Completed

Conditions: Recurrent and/or Metastatic Platinum-refractory SCCHN

Interventions: Drug: Nivolumab Injection

First Posted Date: 2017-07-24

Last Posted Date: 2023-01-18

Lead Sponsor: UNICANCER

Target Recruit Count: 351

Registration Number: NCT03226756

Locations: 🇫🇷
Centre Jean Perrin, Clermont-Ferrand, France
🇫🇷
Centre Antoine Lacassagne, Nice, France
🇫🇷
Centre Paul Strauss, Strasbourg, France

and more 15 locations

QUALIOR Feasibility and Efficacy of a Supervised Home-based Standard Physical Exercise Program

Not Applicable

Active, not recruiting

Conditions: Home Based Standardised Adapted Physical Activity Programme
Patients Taking Oral Targeted Therapy for Metastatic Cancer

Interventions: Behavioral: Supervised physical exercise programs
Behavioral: Adapted physical activity

First Posted Date: 2017-05-30

Last Posted Date: 2024-11-11

Lead Sponsor: UNICANCER

Target Recruit Count: 190

Registration Number: NCT03169075

Locations: 🇫🇷
CH Annecy Genevois - site d'Annecy, Annecy, France
🇫🇷
Centre François Baclesse, Caen, France
🇫🇷
CHD Vendée, La Roche-sur-Yon, France

and more 12 locations

Improving SUrgery of Liver Metastases: a Trial of the Arterial Chemotherapy Network

Phase 2

Completed

Conditions: Colorectal Cancer Metastatic

Interventions: Drug: Oxaliplatin, Cetuximab, Bevacizumab, Panitumumab, Irinotecan, Leucovorin, 5-Fluorouracil

First Posted Date: 2017-05-23

Last Posted Date: 2024-09-30

Lead Sponsor: UNICANCER

Target Recruit Count: 20

Registration Number: NCT03164655

Locations: 🇫🇷
Ico Paul Papin, Angers, France
🇫🇷
Centre Eugene Marquis, Rennes, France
🇫🇷
Gustave Roussy, Villejuif, France

and more 1 locations

Standard Treatment +/- SBRT in Solid Tumors Patients With Between 1 and 5 Bone-only Metastases

Not Applicable

Active, not recruiting

Conditions: Metastatic Breast Cancer
Metastatic Prostate Cancer
Metastatic Lung Cancer
Bone Metastases

Interventions: Radiation: SBRT

First Posted Date: 2017-05-08

Last Posted Date: 2024-11-26

Lead Sponsor: UNICANCER

Target Recruit Count: 168

Registration Number: NCT03143322

Locations: 🇫🇷
ICO - Site Paul Papin, Angers, France
🇫🇷
Centre Catalan D'Oncologie, Perpignan, France
🇫🇷
Centre Marie Curie, Arras, France

and more 25 locations

Nivolumab in Recurrent or Metastatic Salivary Gland Carcinoma of the Head and Neck

Phase 2

Completed

Conditions: Salivary Gland Carcinoma
Metastatic Cancer
Recurrent Cancer

Interventions: Drug: Nivolumab

First Posted Date: 2017-04-27

Last Posted Date: 2022-01-11

Lead Sponsor: UNICANCER

Target Recruit Count: 98

Registration Number: NCT03132038

Locations: 🇫🇷
CHU Bordeaux, Bordeaux, France
🇫🇷
Centre Georges François Leclerc, Dijon, France
🇫🇷
Centre Léon Bérard, Lyon, France

and more 8 locations

Hypofractionated vs Standard Radiotherapy in Breast Cancer With an Indication for Regional Lymph Node Irradiation About Lymphedema Occurrence

Not Applicable

Active, not recruiting

Conditions: Breast Cancer Female

Interventions: Radiation: NORMOFRACTIONATED
Radiation: HYPOFRACTIONATED

First Posted Date: 2017-04-25

Last Posted Date: 2024-04-09

Lead Sponsor: UNICANCER

Target Recruit Count: 1265

Registration Number: NCT03127995

Locations: 🇫🇷
Institut Claudius Regaud, Toulouse, France
🇫🇷
Clinique de l'Europe, Amiens, France
🇫🇷
Institut de Cancerologie de L'Ouest-Rene Gauducheau, Saint-Herblain, France

and more 25 locations

Treatment of Metastatic Castrate Resistant Prostate Cancer Patients According to Circulating Tumor Cells Kinetic

Phase 2

Completed

Conditions: Circulating Tumor Cells
Chemotherapy
Prostate Carcinoma
Castration-resistant Prostate Cancer

Interventions: Drug: Cabazitaxel
Drug: Docetaxel

First Posted Date: 2017-04-04

Last Posted Date: 2022-02-10

Lead Sponsor: UNICANCER

Target Recruit Count: 40

Registration Number: NCT03101046

Locations: 🇫🇷
ICO-Site René Gauducheau, Saint-Herblain, France
🇫🇷
Centre Léon Berard, Lyon, France
🇫🇷
CHD Vendée, La Roche-sur-Yon, France

and more 2 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy